MOMA Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

MOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts. It focuses on developing precision medicines by targeting highly dynamic proteins implicated in human disease, employing small molecules as the therapeutic modality. The company relies on a proprietary platform designed to exploit conformational changes in these proteins to reveal therapeutic vulnerabilities. It concentrates on genetically validated targets with strong potential to translate into clinical benefit and aims to advance its pipeline toward human testing.

The firm collaborates with established pharmaceutical partners to validate targets and progress programs. In January 2024, MOMA announced a five-year discovery collaboration with Roche to explore cancer dependencies. The company operates as a small to mid-sized organization within the biotechnology research sector.

Sign up for free to view info

Company overview Employee directory